Adaptimmune Therapeutics (ADAP)
(Delayed Data from NSDQ)
$0.84 USD
0.00 (0.14%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $0.86 +0.02 (2.05%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMKey Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.17 | 0.00% |
Earnings Summary
For their last quarter, Adaptimmune Therapeutics (ADAP) reported earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.00 per share. This reflects a breakeven earnings surprise. Look out for ADAP's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year increase of 15%.
Earnings History
Price & Consensus
Zacks News for ADAP
Adaptimmune (ADAP) Down on End of Collaboration With Roche
ADAP: What are Zacks experts saying now?
Zacks Private Portfolio Services